Synergistic potential of sipuleucel-T in enhancing immunotherapy for metastatic castration-resistant prostate cancer.

Saved in:
Bibliographic Details
Title: Synergistic potential of sipuleucel-T in enhancing immunotherapy for metastatic castration-resistant prostate cancer.
Authors: Rawat K; Division of Oncology, Department of Medicine, Washington University School of Medicine in Saint Louis, St Louis, Missouri, USA., Punia V; Government Medical College and Hospital, Chandigarh, Punjab and Haryana, India., Mathews P; Department of Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri, USA., McCoy S; Division of Oncology, Department of Medicine, Washington University School of Medicine in Saint Louis, St Louis, Missouri, USA., Song W; Division of Oncology, Department of Medicine, Washington University School of Medicine in Saint Louis, St Louis, Missouri, USA., Saeed MA; Division of Oncology, Department of Medicine, Washington University School of Medicine in Saint Louis, St Louis, Missouri, USA., Pachynski RK; Division of Oncology, Department of Medicine, Washington University School of Medicine in Saint Louis, St Louis, Missouri, USA rkpachynski@wustl.edu.; Siteman Cancer Center, St Louis, Missouri, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Dec 05; Vol. 13 (12). Date of Electronic Publication: 2025 Dec 05.
Publication Type: Journal Article; Review
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2025-012690